These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 1686284)

  • 1. Rescue of dying neurons: a new action for deprenyl in MPTP parkinsonism.
    Tatton WG; Greenwood CE
    J Neurosci Res; 1991 Dec; 30(4):666-72. PubMed ID: 1686284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does melatonin help save dopaminergic cells in MPTP-treated mice?
    Ma J; Shaw VE; Mitrofanis J
    Parkinsonism Relat Disord; 2009 May; 15(4):307-14. PubMed ID: 18793863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity.
    Muralikrishnan D; Samantaray S; Mohanakumar KP
    Synapse; 2003 Oct; 50(1):7-13. PubMed ID: 12872288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective effects of (+/-)-kavain in the MPTP mouse model of Parkinson's disease.
    Schmidt N; Ferger B
    Synapse; 2001 Apr; 40(1):47-54. PubMed ID: 11170221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotection in Parkinson models varies with toxin administration protocol.
    Anderson DW; Bradbury KA; Schneider JS
    Eur J Neurosci; 2006 Dec; 24(11):3174-82. PubMed ID: 17156378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tyrosine hydroxylase-immunohistochemical study in the midbrain of experimental MPTP parkinsonism].
    Fukuda T; Tanaka J; Hasumura M
    Rinsho Shinkeigaku; 1992 Feb; 32(2):161-5. PubMed ID: 1351802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotection of midbrain dopaminergic cells in MPTP-treated mice after near-infrared light treatment.
    Shaw VE; Spana S; Ashkan K; Benabid AL; Stone J; Baker GE; Mitrofanis J
    J Comp Neurol; 2010 Jan; 518(1):25-40. PubMed ID: 19882716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of L-deprenyl treatment, alone and combined with GM1 ganglioside, on striatal dopamine content and substantia nigra pars compacta neurons.
    Rothblat DS; Schneider JS
    Brain Res; 1998 Jan; 779(1-2):226-30. PubMed ID: 9473679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.
    Saporito MS; Brown EM; Miller MS; Carswell S
    J Pharmacol Exp Ther; 1999 Feb; 288(2):421-7. PubMed ID: 9918541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased expression of kynurenine aminotransferase-I (KAT-I) in the substantia nigra of mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment.
    Knyihár-Csillik E; Csillik B; Pákáski M; Krisztin-Péva B; Dobó E; Okuno E; Vécsei L
    Neuroscience; 2004; 126(4):899-914. PubMed ID: 15207325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Broad neuroprotective profile of nicotinamide in different mouse models of MPTP-induced parkinsonism.
    Anderson DW; Bradbury KA; Schneider JS
    Eur J Neurosci; 2008 Aug; 28(3):610-7. PubMed ID: 18702732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen attenuates the MPTP-induced loss of dopamine neurons from the mouse SNc despite a lack of estrogen receptors (ERalpha and ERbeta).
    Shughrue PJ
    Exp Neurol; 2004 Dec; 190(2):468-77. PubMed ID: 15530885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-dependent destruction of the coeruleus-cortical and nigral-striatal projections by MPTP.
    Seniuk NA; Tatton WG; Greenwood CE
    Brain Res; 1990 Sep; 527(1):7-20. PubMed ID: 1980841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in nigral neuron number and sensitivity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57/bl and CD-1 mice.
    Muthane U; Ramsay KA; Jiang H; Jackson-Lewis V; Donaldson D; Fernando S; Ferreira M; Przedborski S
    Exp Neurol; 1994 Apr; 126(2):195-204. PubMed ID: 7925820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice.
    Kurosaki R; Muramatsu Y; Kato H; Watanabe Y; Imai Y; Itoyama Y; Araki T
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):57-67. PubMed ID: 15572274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine)-induced apoptosis in nigral neurons of mice.
    Aoki E; Yano R; Yokoyama H; Kato H; Araki T
    Exp Mol Pathol; 2009 Feb; 86(1):57-64. PubMed ID: 19027004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photobiomodulation enhances nigral dopaminergic cell survival in a chronic MPTP mouse model of Parkinson's disease.
    Peoples C; Spana S; Ashkan K; Benabid AL; Stone J; Baker GE; Mitrofanis J
    Parkinsonism Relat Disord; 2012 Jun; 18(5):469-76. PubMed ID: 22285756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen down-regulates glial activation in male mice following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxication.
    Tripanichkul W; Sripanichkulchai K; Finkelstein DI
    Brain Res; 2006 Apr; 1084(1):28-37. PubMed ID: 16564034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous regeneration of nigrostriatal dopaminergic neurons in MPTP-treated C57BL/6 mice.
    Mitsumoto Y; Watanabe A; Mori A; Koga N
    Biochem Biophys Res Commun; 1998 Jul; 248(3):660-3. PubMed ID: 9703982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selegiline can mediate neuronal rescue rather than neuronal protection.
    Tatton WG
    Mov Disord; 1993; 8 Suppl 1():S20-30. PubMed ID: 8302304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.